这个博客是从Springeropen博客。

Prof. Reekers, can you tell us about the CIRSE society and their support and involvement in the journal? What made the society decide to partner with SpringerNature to launchCVIR血管内？

欧洲的心血管和介入放射学会（CIRSE）是一个非营利的科学和教育学会，成立于1985年，目的是“通过支持心血管领域的教学，科学，研究和临床实践来改善患者护理和介入放射学”。

该协会目前拥有7,000多名学术成员，全球外展涵盖了38个欧洲和国际IR社会。随着越来越多的手稿提交给CIRSE的长期影响因子杂志CVIR - 心血管和介入放射学，很明显，有一个完全专用于血管内疗法领域的额外衍生杂志。

Cirse认识到并理解了IR和血管内疗法的不断发展和稳定发展的基本沟通。CVIR血管内因此，将为与同龄人的交流提供新的低进入领奖台，该领奖台旨在为所有在血管内治疗领域工作的专家。

Without the support of CIRSE and the CIRSE Office in Vienna, this project would not be possible. To work with SpringerNature as the publishing partner was a logical decision as we already partner with Springer on the publication of CVIR.

What do you see as being some of the key opportunities and challenges for the future of the journal’s field?

The field of endovascular treatment is very dynamic and we hope thatCVIR血管内会镜像。关键机会CVIR血管内前进将是大型全球社区中新想法的快速交流和快速交流。

CVIR血管内is a multidisciplinary open access journal and the first open peer-review journal in the field of endovascular interventions.

CVIR血管内is a multidisciplinary open access journal and the first open peer-review journal in the field of endovascular interventions. The journal shall serve as a podium for case reports, small case series, first in man, hypothesis, short communications, study protocols as well as, of course, clinical investigations, technical reports and systematic reviews.

作为一个电子,开放获取期刊not limited to page budgets or print issues. Many good manuscripts and case reports are currently being rejected by other journals because of these restrictions. This will not be the case withCVIR血管内。Manuscripts which receive a positive review and merit publication will be accepted.

关键挑战将是与作者和CIRSE成员社区合作，以其提交的意见来支持该期刊，并在适当的时候为期刊获得影响因素。

What do you think are the advantages of open access journals?

The greatest advantage is the unrestricted availability of content to everybody. Readers don’t need a membership or subscription to access full text manuscripts or download a paper. By this, authors achieve an unparalleled distribution of their work, something every author wants. Isn’t it what makes us write papers: to share our work with others?

另一个优点是作者保留其工作的权利，因此也可以将材料用于其他目的。

CVIR血管内是介入放射学领域的第一个开放式同行评审期刊。为什么打开同行评审？

这必须在新的科学透明度的背景下看到。我认为公开同行评审是未来。我们可能只是领跑者之一。

同行评审将不再是简单的判断。它将成为对话。

我选择介绍这种新的同行评审模型来鼓励讨论。要让审稿人与文章一起发表评论，并向每个人展示以下文章的评论，文章将将审稿人的角色从“快速法官”更改为导师，允许作者和读者访问有用的其他信息。

这也可能会减少挫败感，例如作者的感觉，即审稿人没有认真对待论文，也没有花费足够的时间来真正正确评估它。有了开放的同行评审，审稿人将成为帮助手稿更好的人。

同行评审将不再是简单的判断。它将成为对话，如果接受手稿，所有读者都可以看到。现在，我们有6个月的开放同行评审经验，由于这种新方法，我没有看到任何审稿人在下降。

您对日记的未来有何看法？

我希望CVIR血管内will become an important and internationally recognized podium for scientific and educational publications. Alongside ofCVIRit shall become the next important forum for manuscripts published by CIRSE members and all other specialists involved in endovascular therapy.

我认为这个概念是正确的：我们通过强大的出版物合作伙伴提供开放访问，开放的同行评审，无限的全球分销。在接下来的几年中，我们需要学术界的支持来拥抱CIRSE Publications家族的新成员。

I therefore cordially invite all my colleagues to submit their contributions, to act as reviewers and to spread the word to motivate others to do the same. As we gain momentum, our vision of a new exciting platform for endovascular science and education will become true.